Reports & Papers

Since its founding in 1948, Israel has been engaged in a series of forever wars. After each war, the IDF, Mossad, Shin Bet, and others in the intelligence and security community analyze what happened and summarize their findings in after-action, or “lessons learned,” reports. Former leaders from these institutions, many of whom retain close relations with their successors, also produce reports on what happened and identify takeaways for the future. Thus, in trying to make sense of what’s happening now, lessons these experts have distilled from their experiences provide a sound starting point.

This essay makes three arguments. First, the US government will need to establish a coronavirus commission, similar to the 9/11 commission, to determine why, since April 2020, the United States has suffered more coronavirus fatalities than any other country in the world. Second, the COVID-19 pandemic represents a watershed for what will be a major national security theme this century: biological threats, both from naturally occurring pathogens and from synthesized biology. Third, intelligence about globalized challenges, such as pandemics, needs to be dramatically reconceptualized, stripping away outmoded levels of secrecy.

Many are looking to digital contact tracing to assist reopening efforts, especially in light of reports that the U.S. could expect as many as 100,000 more deaths due to the virus by this Fall. This report focuses on how the U.S. might consider various proposed solutions.

We believe there are real benefits, challenges, and even potential harms in using digital solutions in the fight against COVID-19, but we must also acknowledge that the promise of any technology and associated systems to assist manual contact tracing efforts is largely hypothetical in the United States. There is not one catch-all answer; the truth is that technology is not a panacea, but it may be able to assist official efforts at an unprecedented time. However, no technological solution can succeed without two specific factors: public trust and buy-in, and rapid, widespread testing for everyone living in the U.S. To achieve the first, a number of factors must be addressed by officials in the states looking to implement digital solutions, and by technology developers.
 

In this piece, we will look at the various public purpose considerations as they relate to the development of diagnostics, therapeutics, and vaccines for coronavirus. 

With reservations about venturing into territory outside our normal wheelhouse, and in full certainty that some of what we write here will in retrospect turn out to have been wrong, a team of researchers at the Belfer Center and I have been collecting all the data we have been able to find about coronavirus, analyzing it to the best of our ability, and debating competing answers to the fundamental questions about the challenge this novel virus poses to our nation.

What follows is our current first-approximation of a work in progress. We are posting at this point in the hope of stimulating a wider debate that will include a much larger number of analysts beyond public health professionals and epidemiologists—including in particular intelligence officers, financial wizards, historians, and others.

Human-centered design (HCD) is a complementary discipline that has its roots in industrial design, the discipline that crafts physical products like phones, guitars, and potato peelers. It leverages the qualitative research methods honed in the social sciences—such as ethnography, contextual inquiry, and targeted observations and interviews—to better understand people and interactions. HCD also considers environments, processes, systems, and tools outside of the digital realm. Practitioners often map out customer “journeys” to understand customer experiences across an entire system or ecosystem, not merely a single interface or piece of software. As in agile software development, practitioners of human-centered design iteratively develop solutions to the challenges they uncover, and they rigorously test their solutions with real “users.”

The Technology Factsheet Series offers a brief overview of the technical aspects of salient technologies and their policy relevance for Congressional members and their staff.

The Technology Factsheet Series offers a brief overview of the technical aspects of salient technologies and their policy relevance for Congressional members and their staff.

The Technology Factsheet Series offers a brief overview of the technical aspects of salient technologies and their policy relevance for Congressional members and their staff. 

The Technology Factsheet Series offers a brief overview of the technical aspects of salient technologies and their policy relevance for Congressional members and their staff.